Related Experiment Video
Updated: Jun 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Correlation between circ_0092576 and Arterial Stenosis Severity and Inflammatory Status in Patients with Coronary
Wenqin Dai1, Lingli Wang2, Yuan Li3
1Department of Cardiology, Wuhan Wuchang Hospital, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, 430063, Hubei, China.
Insights
Circular RNA circ_0092576 shows promise as a biomarker for coronary heart disease (CHD). Higher levels predict increased CHD risk, severe stenosis, inflammation, and major adverse cardiac events (MACE).
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Biomarker Discovery
Background:
- Coronary heart disease (CHD) poses a significant global health burden.
- Identifying reliable biomarkers for CHD risk and prognosis is crucial for early intervention.
- The role of circular RNAs (circRNAs) in cardiovascular diseases is an emerging area of research.
Purpose of the Study:
- To evaluate the predictive value of circ_0092576 for CHD and major adverse cardiac events (MACE).
- To investigate the association between circ_0092576 levels and coronary artery stenosis severity.
- To explore the relationship between circ_0092576 and inflammatory markers in CHD patients.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) was used to measure plasma levels of circ_0092576, IL-1β, TNF-α, and IL-10.
- Gensini score system assessed coronary artery stenosis severity.
- Patient follow-up was conducted to record MACE occurrence.
Main Results:
- circ_0092576 levels were significantly elevated in CHD patients compared to controls (AUC=0.885).
- circ_0092576 positively correlated with Gensini scores, IL-1β, and TNF-α, and negatively with IL-10.
- Higher circ_0092576 levels were associated with increased MACE risk and cumulative incidence.
Conclusions:
- circ_0092576 is a potential biomarker for CHD risk and prognosis.
- Elevated circ_0092576 levels indicate higher risk of CHD, more severe coronary artery stenosis, and increased inflammation.
- circ_0092576 may serve as a predictor for adverse cardiac events in CHD patients.
Abstract:
This study aims to investigate the predictive value of circ_0092576 for coronary heart disease (CHD) and major adverse cardiac events (MACE) risk, and to elucidate its association with the degree of coronary artery stenosis and inflammatory status. A total of 200 CHD patients and 180 non-CHD controls were recruited. Plasma levels of circ_0092576, IL-1β, TNF-α and IL-10 were measured using RT-qPCR. Coronary artery stenosis severity was assessed using the Gensini score system, and MACE occurrence was recorded during regular follow-up. circ_0092576 levels were significantly higher in CHD patients than in the control group, with an area under the ROC curve (AUC) of 0.885. Furthermore, circ_0092576 showed significant positive correlations with Gensini scores and pro-inflammatory factors IL-1β and TNF-α while exhibiting a negative correlation with the anti-inflammatory factor IL-10. Follow-up revealed significantly elevated circ_0092576 levels in patients who developed MACE. Compared to the low circ_0092576 group, the high circ_0092576 group exhibited a significantly higher cumulative incidence of MACE. Elevated circ_0092576 levels correlate with increased risk of CHD and subsequent MACE. In summary, circ_0092576 is a potential biomarker for CHD risk and prognosis. Elevated levels indicate increased risk of CHD, more severe coronary artery stenosis, stronger inflammation, and are associated with an increased risk of adverse cardiac events.
Related Concept Videos
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies